TGF-β has also been shown to promote tumor cell plasticity through activation of multiple EMT transcriptional factors and immune suppression in the TME by T cell exclusion, resulting in resistance to immunotherapy[135-137]. This evidence concerns the gene TGFB1 and neoplasm.